Sharps Technology Receives Purchase Orders for 1 Million SecureGard Syringes for 2024 Delivery
July 03 2024 - 1:05PM
Sharps Technology, Inc., (NASDAQ: “STSS” and “STSSW”), an
innovative medical device and pharmaceutical packaging company
offering patented, best-in-class prefillable and disposable syringe
products has received two purchase orders for a total of
approximately 1 million SecureGard ultra-low waste smart safety
syringes produced at Sharps’ manufacturing facility in Hungary. The
first 100k syringe shipment is scheduled for the third week of
July, and subsequent deliveries will be made throughout the rest of
2024. Sharps is working to create a long-term, strategic
partnership with the customer, a major Swiss-based global provider
of cosmetic, dental, and ophthalmic injectable therapies. The
initial 1mL SecureGard syringe orders are a first step in a
collaboration that can leverage Sharps’ innovative technology,
portfolio of drug delivery solutions, and development expertise to
support the customer’s growing product offerings.
The need for innovative injection solutions
continues to grow rapidly as injectables are the first choice for
therapies as diverse as vaccines, biologics, weight loss and
maintenance, ophthalmic and cosmetic applications, gene therapies,
and diabetes and inflammatory disease management. As a result of
this market growth and the impact of the tariffs, recalls, and
quality issues with Chinese supplied syringes, Sharps is seeing
increasing levels of interest and potential demand for its high
quality smart safety syringe products.
Sharps Technology specializes in the development
and manufacturing of innovative drug delivery systems. The
Company’s SecureGard and SoloGard product lines focus on low waste
and ultra-low waste syringe technologies that incorporate active
safety features as well as World Health Organization accredited
re-use prevention measures. These features protect front line
healthcare workers from life-threatening needle stick injuries and
protect the public from the dangers of needle re-use. Sharps has a
manufacturing facility in Hungary and is currently working to close
on its recent asset acquisition in South Carolina to expand its
manufacturing capacity in the U.S.
For more information about the Company, please
visit http://sharpstechnology.com.
FORWARD-LOOKING STATEMENTS:This
press release contains “forward-looking statements”.
Forward-looking statements reflect our current view about future
events. When used in this press release, the words “anticipate,”
“believe,” “estimate,” “expect,” “future,” “intend,” “plan,”
“poised” or the negative of these terms and similar expressions, as
they relate to us or our management, identify forward-looking
statements. Such statements, include, but are not limited to,
statements contained in this press release relating to our business
strategy, our future operating results and liquidity, and capital
resources outlook. Forward-looking statements are based on our
current expectations and assumptions regarding our business, the
economy, and other future conditions. Because forward–looking
statements relate to the future, they are subject to inherent
uncertainties, risks, and changes in circumstances that are
difficult to predict. Our actual results may differ materially from
those contemplated by the forward-looking statements. They are
neither statements of historical fact nor guarantees of assurance
of future performance. We caution you therefore against relying on
any of these forward-looking statements. Important factors that
could cause actual results to differ materially from those in the
forward-looking statements include, without limitation, our ability
to raise capital to fund continuing operations; our ability to
protect our intellectual property rights; the impact of any
infringement actions or other litigation brought against us;
competition from other providers and products; our ability to
develop and commercialize products and services; changes in
government regulation; our ability to complete capital raising
transactions; and other factors relating to our industry, our
operations and results of operations. Actual results may differ
significantly from those anticipated, believed, estimated,
expected, intended, or planned. Factors or events that could cause
our actual results to differ may emerge from time to time, and it
is not possible for us to predict all of them. We cannot guarantee
future results, levels of activity, performance, or achievements.
The Company assumes no obligation to update any forward-looking
statements in order to reflect any event or circumstance that may
arise after the date of this release.
Investor Relations:Dave GentryRedChip Companies,
Inc.1-800-RED-CHIP (733-2447)Or 407-644-4256STSS@redchip.com
Sharps Technology (NASDAQ:STSSW)
Historical Stock Chart
From Oct 2024 to Nov 2024
Sharps Technology (NASDAQ:STSSW)
Historical Stock Chart
From Nov 2023 to Nov 2024